darolutamide,
ODM-201,
ORM-16497,
ORM-16555,
Darolutamide,
ODM-201,
1297538-32-9,
BAY-1841788,
N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide,
ODM201,
N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide,
UNII-X05U0N2RCO,
X05U0N2RCO,
1H-Pyrazole-3-carboxamide, N-((1S)-2-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-,
1H-Pyrazole-3-carboxamide, N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-,
Darolutamide [USAN],
Darolutamide (ODM-201),
Darolutamide (JAN/USAN/INN),
SCHEMBL1814935,
SCHEMBL13733117,
KS-00000TSX,
EX-A759,
BLIJXOOIHRSQRB-PXYINDEMSA-N,
BDBM309979,
MFCD29472270,
AKOS030526387,
BAY1841788,
CS-5174,
DB12941,
SB18882,
BAY 1841788,
NCGC00484078-01,
HY-16985,
ODM-201;BAY-1841788,
FT-0700158,
S7559,
J3.501.129C,
D11045,
US9657003, 56,
J-690121,
1-[(2S)-2-Butanyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-car boxamide,
N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((1RS)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide,
N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol -1-yl)propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide,
N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxy-ethyl)-1H-pyrazole-3-carboxamide,